You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

456 Results
Document
Mar 2018
Document
Mar 2018
Document
Mar 2018
Document
Apr 2018
Document
Apr 2018
Document
Apr 2018
Document
Apr 2018
Drug
Other Name(s): Oncaspar®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 2022
Guidelines and Advice
Status: Current
Version: 2
May 2021
Guidelines and Advice
Status: Current
ID: PET 2017-2
Version: n/a
May 2018
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab,
pemetrexed
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2023
Document
Jul 2018

Pages